Dimethyl phosphate tablets (Astomin) were developed by OrphanPacific in Japan. In 1975, this drug was first approved for marketing in Japan for the treatment of cough.

1、 Drug name

1. Common name: Dimemorfan Phosphate

2. Product Name: AstominTablets 10mg

2、 Indications

Used to treat cough associated with the following diseases:.

1. Upper airway inflammation, pneumonia, acute bronchitis

2. Tuberculosis, pulmonary and pelvic tuberculosis, lung cancer, chronic bronchitis.

3、 Specifications and characteristics

1. Specification: Sugar coated tablets, each containing 10mg of Olaf.

2. Appearance: White tablet, diameter 6.9mm, thickness 3.4mm, mass 140mg, surface printed with the "AstraZeneca" logo.

4、 Main components

1. Active ingredient: Mejil acid.

2. Accessories: 12 types of excipients including anhydrous calcium hydrogen phosphate, microcrystalline cellulose, light anhydrous silicic acid, lactose, etc.

5、 Usage and dosage

1. Adults (over 15 years old): Take 1-2 tablets (10-20mg) orally three times a day.

2. It can be adjusted appropriately according to age and symptoms.

6、 Dose adjustment

1. High risk individuals: need to reduce dosage (due to a general decrease in physiological function).

2. Patients with liver and kidney dysfunction: Not clearly stated, it is recommended to use with caution.

7、 Medication precautions

1. Medication time: No specific requirement before or after meals.

2. Leakage: No specific handling method was mentioned.

3. Vomiting: If vomiting occurs after taking medication, it should be supplemented (time interval not specified).

4. PTP packaging requires taking out the tablets to prevent accidental ingestion of the packaging and damage to the esophagus.

8、 Medication for special populations

1. Pregnant women: Use only when the benefits of treatment outweigh the risks.

2. Breastfeeding women need to balance the necessity of treatment with the benefits of breastfeeding.

3. Diabetes: May cause slight changes in glucose tolerance.

4. Children: Safety has not been established for those under 15 years old.

9、 Adverse reactions

Occurrence rate ≥ 0.1%:

1. Nervous system: dizziness, drowsiness, headache.

2. Digestive system: dry mouth, loss of appetite, nausea and vomiting.

3. Allergic reaction: rash.

4. Circulating system: tachycardia, palpitations.

10、 Contraindications

Absolute contraindications are not explicitly listed, but they are contraindicated for those who are allergic to the ingredients.

11、 Drug interactions

There are no specific drugs with obvious interactions.

12、 Storage method

Store at room temperature (specific temperature range not specified).

Validity period: 3 years.

Astomininformation